Total Payments
$279,155
2024 Payments
$13,818
Companies
11
Transactions
280
Medicare Patients
402
Medicare Billing
$42,525
Payment Breakdown by Category
Other$229,625 (82.3%)
Travel$39,937 (14.3%)
Food & Beverage$7,394 (2.6%)
Consulting$2,200 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $229,625 | 61 | 82.3% |
| Travel and Lodging | $39,937 | 128 | 14.3% |
| Food and Beverage | $7,394 | 89 | 2.6% |
| Consulting Fee | $2,200 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $273,910 | 246 | $0 (2024) |
| Bovie Medical Corporation | $2,328 | 4 | $0 (2017) |
| Medical Device Business Services, Inc. | $1,331 | 6 | $0 (2018) |
| Ethicon US, LLC | $577.03 | 8 | $0 (2023) |
| AngioDynamics, Inc. | $456.40 | 1 | $0 (2018) |
| TerSera Therapeutics LLC | $239.97 | 3 | $0 (2023) |
| Boston Scientific Corporation | $107.21 | 2 | $0 (2023) |
| Wound Management Technologies, Inc | $76.66 | 3 | $0 (2019) |
| Sirtex Medical Inc | $58.49 | 1 | $0 (2018) |
| TELA Bio, Inc. | $56.16 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,818 | 14 | Ipsen Biopharmaceuticals, Inc ($13,818) |
| 2023 | $29,862 | 22 | Ipsen Biopharmaceuticals, Inc ($29,467) |
| 2022 | $14,316 | 11 | Ipsen Biopharmaceuticals, Inc ($14,127) |
| 2021 | $24,680 | 14 | Ipsen Biopharmaceuticals, Inc ($24,680) |
| 2020 | $6,429 | 7 | Ipsen Biopharmaceuticals, Inc ($6,323) |
| 2019 | $56,016 | 54 | Ipsen Biopharmaceuticals, Inc ($55,907) |
| 2018 | $32,863 | 39 | Ipsen Biopharmaceuticals, Inc ($30,769) |
| 2017 | $101,171 | 119 | Ipsen Biopharmaceuticals, Inc ($98,819) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,830.00 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $724.40 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $208.18 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $173.66 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $83.75 | General |
| Category: Oncology | ||||||
| 05/20/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,070.00 | General |
| Category: Oncology | ||||||
| 03/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $206.41 | General |
| Category: Oncology | ||||||
| 03/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Oncology | ||||||
| 03/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Oncology | ||||||
| 03/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Oncology | ||||||
| 03/01/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $792.05 | General |
| Category: Oncology | ||||||
| 03/01/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,140.00 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $295.00 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Boston Scientific Corporation | Axios (Device) | Food and Beverage | In-kind items and services | $50.18 | General |
| Category: Axios_ENDO | ||||||
| 11/16/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,680.00 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $722.24 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $402.80 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Oncology | ||||||
| 10/16/2023 | Boston Scientific Corporation | Axios (Device) | Food and Beverage | In-kind items and services | $57.03 | General |
| Category: Axios_ENDO | ||||||
| 08/24/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,680.00 | General |
| Category: Oncology | ||||||
| 08/24/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $450.79 | General |
| Category: Oncology | ||||||
| 08/24/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $236.83 | General |
| Category: Oncology | ||||||
| 08/24/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $132.38 | General |
| Category: Oncology | ||||||
| 08/24/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 69 | 113 | $31,723 | $9,344 |
| 2022 | 4 | 90 | 168 | $37,940 | $10,323 |
| 2021 | 5 | 105 | 172 | $35,625 | $9,892 |
| 2020 | 5 | 138 | 219 | $45,210 | $12,966 |
Total Patients
402
Total Services
672
Medicare Billing
$42,525
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 41 | $13,489 | $4,003 | 29.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 45 | $9,855 | $2,860 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 16 | $4,320 | $1,278 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $4,059 | $1,203 | 29.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 101 | $19,796 | $5,497 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 31 | $8,432 | $2,171 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 14 | $5,642 | $1,576 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 22 | $4,070 | $1,078 | 26.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 45 | 111 | $21,090 | $5,737 | 27.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $6,874 | $2,054 | 29.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 18 | 18 | $3,978 | $1,051 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 16 | $2,864 | $775.85 | 27.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 13 | 13 | $819.00 | $273.73 | 33.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 62 | 138 | $28,566 | $8,164 | 28.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 20 | 20 | $7,400 | $2,292 | 31.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 19 | 19 | $4,123 | $1,119 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 24 | 29 | $4,263 | $1,074 | 25.2% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 13 | 13 | $858.00 | $316.29 | 36.9% |
About Dr. Omar Barakat, MD
Dr. Omar Barakat, MD is a Surgery healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649260969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Omar Barakat, MD has received a total of $279,155 in payments from pharmaceutical and medical device companies, with $13,818 received in 2024. These payments were reported across 280 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($229,625).
As a Medicare-enrolled provider, Barakat has provided services to 402 Medicare beneficiaries, totaling 672 services with total Medicare billing of $42,525. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Surgical Oncology, Specialist
- Location Houston, TX
- Active Since 10/27/2005
- Last Updated 11/20/2023
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1649260969
Products in Payments
- Somatuline Depot 120mg-.5ml (Drug) $97,541
- ONIVYDE (Drug) $59,502
- Onivyde (Drug) $48,061
- SOMATULINE DEPOT (Drug) $41,552
- Somatuline Depot (Drug) $26,243
- HARMONIC Product Family (Device) $1,331
- Xermelo (Drug) $239.97
- Echelon Flex (Device) $148.73
- ENSEAL Product Family (Device) $124.99
- ECHELON FLEX Stapler (Device) $124.21
- Axios (Device) $107.21
- NEUWAVE Flex Microwave Ablation System (Device) $105.75
- CellerateRx (Device) $76.66
- Enseal (Device) $73.35
- SIR-Spheres Microspheres (Device) $58.49
- Ovitex (Device) $56.16
- Axonics (Device) $14.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Houston
Samir Awad, Md, MD
Surgery — Payments: $1.5M
Surgery $1.5M
Gustavo Oderich, Md, MD
Surgery — Payments: $568,544
Surgery $568,544
Ali Azizzadeh Fard, M.d, M.D
Surgery — Payments: $334,137
Surgery $334,137
Dr. Robert Southard, Md, MD
Surgery — Payments: $305,944
Surgery $305,944
Dr. Edward Chang, M.d, M.D
Surgery — Payments: $181,536
Surgery $181,536
Gabriel Loor, Md, MD
Surgery — Payments: $136,407
Surgery $136,407